Decentralized Clinical Trials
Fully enabled digital transformation of clinical trials
The PPD™ clinical research business of Thermo Fisher Scientific pioneers digital capabilities and deploys solutions to streamline protocols, putting patient experience at the center of every design. Recently recognized by ISG as a leader in the design and deployment of decentralized clinical trial solutions, and patient engagement services, our teams can help you drive recruitment, engagement, retention and data quality.
We have been recognized by ISG as an industry leader in clinical development digital transformation services and patient engagement digital transformation
Our capabilities
Every day, customers choose us to digitally transform traditional study designs, ensure business continuity and advance lifesaving clinical research around the world.
Telemedicine
Reduce the number of on-site visits for patients
Direct-to/from-patient models
Deliver or collect clinical materials at patient’s home
Remote e-consent
Collect electronic consent or re-consent patients off-site
Home health care & nursing
Bring the study to the patient
eCOA and ePRO
Leverage digitally reported outcomes
Specialized sites
Diversify clinical trial participant populations and reduce burden
Remote monitoring
Maintain oversight of clinical sites and ensure safety
Devices & wearables
Digital tools and resources to enable patient participation
Regulatory insights
Stay up to date with the latest guidance
Choosing decentralized clinical trials
As the clinical landscape continues to evolve, the use of DCT solutions increases, keeping research moving forward and ensuring safety of clinical trials and patients.
DCT therapeutic expertise
Our therapeutic expertise spans the full research and development spectrum of indications, including rare disease, hematology/oncology and women’s health.
Why choose our digital and decentralized solutions
Our expertise supports every stage of the drug development process, helping you pivot to a digital-based trial approach.
